A Clinical Study on Kaphaja Kasa with Drug Madhvasava An Open Labelled Clinical Trial.
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Reduction in the symptoms of kaphaja kasa
研究概览
简要总结
In the pathogenesis of disease Kaphaj Kasa, vitiated Kapha obstructs the free flow of Vayu in Kantha and Uras. Since Kapha is the main culprit in the production of Kasa indulgence in food and activities which aggravate Kapha increases the severity of Kaphaj Kasa. Exposure cold environment, sleeping in daytime usually aggravates Kaphaj Kasa. Thus Vata and Kapha are the two key pathological factors involved in the Samprapti of Kaphaj Kasa. Kaphaj Kasa is the clinical entity in which there is coating of cough in mouth, Kapha sampoorna ura (feeling of phlegm collected in the chest), aversion to food, feeling of heaviness of the body, debility, cough followed by thick sputum.
Madhvasava having Chedi, Tikshna, Kaphaghna and kasahara effects, thus eliminating episodic recurrence of kaphaja kasa and provide a cure from disease to the patient.
Diagnostic Criteria
Kanthoplepa
Asya madhurya
Pinasa
Vaksh sampurnaiv manyate
Ghana – snigdha – sweta – bahul shleshm pravarthanam
Aruchi
Excess quantity of Sputum
Present study is being planned to evaluate the study on Kaphaja kasa with drug Madhvasava. The sample size is 40 patients. Madhvasava will be given in 15 ml dose in muhur muhur dose (6-8 times / day).
Study duration is of 7 days and follow up after 7 days.
Study Design is Open Labelled Clinical Trial.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients willing to participate and give written informed consent.
- •Patients in the age group of 18-70 years of either sex.
- •Patients with signs and symptoms of Kaphaj Kasa.
排除标准
- •Patients below 18 yrs & above 70 yrs.
- •Patients having Pneumonia, Pulmonary Tuberculosis, Pneumothorax, Pleural effusion, Bronchial Asthma, COPD, Bronchiectasis, etc.
- •Any congenital anomalies related to respiratory or cardiovascular systems.
- •The patient suffering from malignant systemic disorders.
- •Patients having Uncontrolled HTN, Poorly controlled Diabetes mellitus, Unstable Angina, Coronary artery disease.
- •Red Flag Signs associated with Cough: Hemoptysis, Breathlessness, Weight Loss, Fever.
- •Patients having severe Renal or any Hepatic disease.
- •Pregnant or lactating females.
- •Acute and serious conditions which require emergency intervention will be excluded.
结局指标
主要结局
Reduction in the symptoms of kaphaja kasa
时间窗: 7 days
次要结局
- Improvement in the symptoms of kaphaja kasa(Day 7)